Company Filing History:
Years Active: 2021-2023
Title: Dawn Adkin: Innovator in Pharmaceutical Compositions
Introduction
Dawn Adkin is a notable inventor based in Loughborough, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for drug administration. With a total of 2 patents to her name, her work is paving the way for advancements in medication delivery systems.
Latest Patents
Dawn Adkin's latest patents focus on "Lisinopril compositions with an ingestible event marker." These compositions are designed for the ingestible administration of lisinopril, a medication commonly used to treat high blood pressure. In some embodiments, the compositions comprise lisinopril and silicon. Additionally, other embodiments include lisinopril, silicon, magnesium metal, and copper (I) chloride. The patents also detail apparatuses that incorporate these compositions and methods for their use.
Career Highlights
Dawn Adkin is currently associated with Otsuka Pharmaceutical Company, Limited, where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to improving drug formulations and enhancing patient outcomes through effective medication delivery.
Collaborations
Dawn has collaborated with several professionals in her field, including Kurt Scheinpflug and Nikhil Pargaonkar. These collaborations have contributed to the development of her patented technologies and have fostered a spirit of innovation within her team.
Conclusion
Dawn Adkin's contributions to pharmaceutical innovations, particularly in the area of lisinopril compositions, highlight her role as a leading inventor in the industry. Her work not only advances medical science but also improves the quality of healthcare for patients.